➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Dow
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
McKesson

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for DS-8500a

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug DS-8500a?

DS-8500a is an investigational drug.

There have been 8 clinical trials for DS-8500a. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2014.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and [disabled in preview]. The leading clinical trial sponsors are Daiichi Sankyo Co., Ltd., Daiichi Sankyo Inc., and Daiichi Sankyo, Inc.

There is one US patent protecting this investigational drug and thirty-two international patents.

Recent Clinical Trials for DS-8500a
TitleSponsorPhase
A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy SubjectsDaiichi Sankyo Inc.Phase 1
A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy SubjectsDaiichi Sankyo Inc.Phase 1
12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on MetforminDaiichi Sankyo Inc.Phase 2

See all DS-8500a clinical trials

Clinical Trial Summary for DS-8500a

Top disease conditions for DS-8500a
Top clinical trial sponsors for DS-8500a

See all DS-8500a clinical trials

International Patents for DS-8500a

Drugname Country Document Number Estimated Expiration Related US Patent
DS-8500a Australia 2011314712 2030-10-14   Start Trial
DS-8500a Brazil 112013009043 2030-10-14   Start Trial
DS-8500a Canada 2814628 2030-10-14   Start Trial
DS-8500a China 103249726 2030-10-14   Start Trial
DS-8500a Colombia 6771403 2030-10-14   Start Trial
DS-8500a Cyprus 1116303 2030-10-14   Start Trial
DS-8500a Denmark 2628733 2030-10-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.